drugset / Trial / NCT03540043
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 2, multicenter, double-blind, placebo control study evaluating the safety and efficacy of Thykamine in adult patient suffering of mild-to-moderate Atopic Dermatitis
Timeline
- Start
- 2017-10-23
- Primary completion
- 2019-12-31
- Completion
- 2020-06-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PUR 0110 | Unknown | 0.05 % | Topical |
| Subject | PUR 0110 | Unknown | 0.1 % | Topical |
| Subject | PUR 0110 | Unknown | 0.25 % | Topical |